Watch out for an itchy, blistering rash with use of vildagliptin

+Practice

In print

Pharmacotherapy

Watch out for an itchy, blistering rash with use of vildagliptin

28 February 2024

By Linda Bryant and Tess James

Wednesday 28 February 2024, 12:40 AM

Over six months, Sam’s skin lesions became blisters [Image: Mohammad2018, CC BY-SA 4.0 via Wikimedia Commons]

This article looks at an autoimmune bullous skin disease that may occur spontaneously but can also be drug induced

Key points, Be alert for vildagliptin-induced skin reactions, even if it has been a long-term medicine used for up to five years. Even after discontinuation of , Pract Green w Pale Yellow

Medicines and Therapies

References

Phan K, Charlton O, Smith SD. Dipeptidyl peptidase-4 inhibitors and bullous pemphigoid: A systematic review and adjusted meta-analysis. Australas J Dermatol 2020;61(1):e15–21.
Silverii GA, Dicembrini I, Nreu B, et al. Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials. Endocrine 2020;69(3):504–07.
Sun L, Wang C, Wu C, et al. Analysis of the clinical characteristics of dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid. Ann Pharmacother 2022;56(2):205–12.
Verheyden MJ, Bilgic A, Murrell DF. A systematic review of drug-induced pemphigoid. Acta Derm Venereol 2020;100(15):adv00224.

How to Treat

Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management

Wednesday 14 August 2024, 12:45 AM